ENTITY
Abbott Laboratories

Abbott Laboratories (ABT US)

149
Analysis
Health CareUnited States
Abbott Laboratories discovers, develops, manufactures, and sells a broad and diversified line of health care products and services. The Company's products include pharmaceuticals, nutritional, diagnostics, and vascular products. Abbott markets its products worldwide through affiliates and distributors.
more
Refresh
bullishS&P 500 INDEX
20 Sep 2017 22:37

Vermilion Macro Vision - U.S. Equity Strategy: Sector Commentaries with Recommendations

Our last strategy “Fake Moves” highlighted our view that the markets were showing no parallel to the “fake news” narrative and indeed provided a...

Logo
414 Views
Share
12 Sep 2017 10:29

Sector Capsule: Baby Food in China

Current value sales grow by 9% in 2017 to reach CNY146.3 billion The second-child policy as well as greater supervision by the government greatly...

Share
bullishS&P 500 INDEX
06 Sep 2017 23:22

U.S. Equity Strategy: Reiterating Biotechs, Gold Miners; Downgrading Financials to Market Weight

Key themes: Downgrading Financials. Given the Sector’s relative deterioration, we are downgrading Financials to market weight. Pockets of strength...

Logo
483 Views
Share
18 Jun 2017 19:55

Spectranetics Nearing Expected FDA Approval of Stellarex

Spectranetics Corp. is expected to receive Food and Drug Administration approval this summer for its drug-coated balloon catheter used to treat...

Logo
CTFN
310 Views
Share
15 Jun 2017 12:02

Eris Lifesciences: Ask Some Questions, Take the Deal

Eris Lifesciences Limited (0113824Z IN) is an India-focused pharmaceutical company that produces and markets branded generic drugs. The company...

Share
x